DOCSLIB.ORG

Cheiating Agents In^Pharmacology, Toxicology and Therapeutics

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cheiating Agents In^Pharmacology, Toxicology and Therapeutics II. INTERNATIONAL SYMPOSIUM 1 INIS-mf--11233 %. -'-;; -r^ >* CHEIATING AGENTS IN^PHARMACOLOGY, TOXICOLOGY AND THERAPEUTICS PILSEN. 12 14 8 1987 2nd International Syaposiua CHELATING AGENTS IN PHARMACOLOGY, TOXICOLOGY AND THERAPEUTICS Pilsen, 12.-14. 8. 1987 organized by THE CZECHOSLOVAK NEOICAL SOCIETY J.E.PURKYNt The Czechoslovak Pharmacological Society in cooperation with THE DEPARTMENT OF PHARMACOLOGY Faculty of Medicine, Charles University Pilsen THE INSTITUTE OF HY6IENE AND EPIDEMIOLOGY Prague Organizing Coeaittee V. Eybl President 0. Maitzovi Secretary D. Caisovi Meabera M. Cikrt M. Koutenski J. Koutensk? J. Sykora A. Zechaeister B This volume contains all abstracts of papers accepted till 15th April 1987 by the Organizing Committee. These abstracts are photographically repro- duced from the original forms submitted by the authors. The authors are responsible for the content and the grammatical style of their abstracts. The papers are arranged in alphabetical order of the authors names. \ ORAL COMMUNI CATIONS EFFECTS OF COMPLEXING THIOLS ON BILIARY EXCRE- TION OF LEAD IN THE RAT J.ALEXANDER, J.AASETH Department of Toxicology, National Institute of Public Health, Geitmyrsvn. 75, 0462 Oslo 4, Norway," Hedemark Central Hospital, Elverum, Norway The fecal route is an important excretory path- way for lead in humans, and may as in the rat be derived from biliary excreted lead. Previous studies indicate that lead is excreted into bi- le by a glutathione dependent mechanism (Ale- xander et al.). The efficiency of therapeutic chelating agents may in addition to enhanced urinary metal excretion also work via an en- creased biliary excretion. Several chelating agents were therefore examined: diethyldithio- carbamate (DDC) BAL, DMSA, N-acetylpenicillami- ne and penicillamine. DDC initially inhibited biliary lead excretion while all of the other J compounds caused an increased biliary lead ex- j cretion in lead exposed rats. Penicillamine 1 was the most efficient compound. Their media- ; nism of action is not clear as their effects .< may either be a result of lead-complexation h within the cell followed by excretion of the complex or indirectly by influencing glutathio- ne metabolism. Increased levels of glutathione in the liver may cause an enhanced lead excre- tion into bile. To prevent reabsorption of bi- liary excreted lead in the gut it is suggested to combine treatment with penicillamine with a nonabsorbable lead chelating agent. Alexander,J., Aaseth, J. and Mikalsen, A. Acta Pharmacol. Toxicol. Suppl. 59, 486-489, 1986. CHELAT1ON OF CADMIUM IN VIVO. Oie Andersen Department of Environmental Medicine, Odense University, 3.B. Winsl#ws Vej 19, DK-5000 Odense C, Denmark. Acute human Cd intoxication is always due to oral or pulmonary exposure, and immediate mortality is caused by gastrointestinal (g.i.) or pulmonary epithelial damage. However, secondary hepatic and renal damage may develop. The acute toxicity of Cd and effects of chelators thereon has mainly been studied experimentally after parenteral exposures, where acute mortality is due to hepatic necrosis. The present work demonstrated that chelating agents could affect the acute toxicity of cadmium quite differently depending on the administration route of both cadmium and chelator. The best example is DDC, which after parenteral administration of both DDC and cadmium is an efficient antidote, but which after oral admini- stration of cadmium increased the acute toxicity of cadmium quite dramatically. Effects of chelators on acute cadmium toxicity was investigated after either oral or intraperitoneal (ip) exposure to both chelator and cadmium. After comparing effects of about 20 chelators, including a number of polyaminopolycarboxylic acids and various derivatives of BAL, DDC and penicillamin, DMSA was found to be superior after oral exposure, while TTHA was superior after ip exposure. Both reduced the retention of cadmium efficiently, and they acted synergistically when administered together (DMSA orally and TTHA ip) 15 min after a highly toxic oral dose of cadmium. Our results corroborate and extend those of Mark Jones and define a very effective chelation antidote treatment of oral cadmium intoxication, which also minimize cadmium retention and thus the risk of secondary systemic toxicity. METABOLIC STUDIES OF MESO-DMSA IN HUMANS Ik VASKEN APOSHIAN, RICHARD M. MAIORINO AND DANA F. PERRY University of Arizona, Tucson, Arizona, USA The presence of oxidized species of meso-2,3,-dimercap- tosuccinic acid in human urines has been determined and quantified. Unaltered DMSA was determined by derivatization of the thiol groups with monobromobirnane (BB). Total DMSA (unaltered and altered) was determined by electrolytic reduction followed by BB derivatization. The bimane deriva- tives were identified and quantified by HPLC and fluorescence. Six male human volunteers were given lOmg DMSAAg po after which their urines were collected during a 14hr period. At the time of writing of this abstract, studies of the urine of three volunteers have been completed. The unaltered DMSA excreted in the urine 14 hrs after DMSA administraton averaged 2.62% of the given dose; the altered DMSA was 20.98%. The peak of excretion of unaltered DMSA and altered DMSA occurred at 2 hrs and 4 hrs, respectively. Based on human and rabbit studies, the * altered DMSA consists of disulfide and tetrasulfide forms of 5 DMSA. The urines are also being analyzed for Cu, Zn and Pb { content. These new methods for the determination of the c dithiols and their oxidized forms should lead to a better i understanding of the metabolic properties of these \ increasingly important, orally effective metal mobilizing agents. EFFECT OF DMPS AND D-PENICILLANINE ON THE LEVEL OF LIPID PEROXIDATION PRODUCTS IN FiETAL-POI SONED RATS L.BENOV, O.PIONOUICH, I.BENCHEV Department of Biophysics, University School of Medicine, 5800 Pleven, Bulgaria The level of lipid peroxidation prooucts (con- jugated diens, lipid hydroperoxides, fluorescence products and malondialdehyde) and the activities of some enzymes protecting the cell against activa- ted oxygen have been studied in copper and mercury poisoned rats, treated with 2,3-dimercapto-1-pro- pane sulfonic acid (DFIPS) or D-penicillamine (DP). It has been found that both thiols significantly inactivated superoxide dismutase in blood, liver ) and kidney in healthy as uell as in metal-poisoned ] rats. The treatment of copoer-poisoned rats with : DMPS or DP caused increase of ("IDA and fluorescence 5, products in the blood. In the liver, houever, DP afforded protection against lipid peroxidation but DHPS did not. Decrease of the level of the lipid peroxidation products has been observed also in the liver of mercury-poisoned rats treated with DPIPS or DP. Neither of the antidotes exerts effect on the level of the lipid peroxidation products in the kidney. 10 CANCER PREVENTION BY CHELATION THERAPY W.BLUMER General Practice, Netstal, Switzerland. The cancer mortality among 331 adult persons living adjacent to an automobile road was found to be 9 times higher than in a traffic-free section of the same town. The inhabitants residing near the road had suffered also very often from haedaches, fatigue, stomach ailments, depressive conditions, nervous trou- bles and tablets-misuse. The existence of small lead deposits as well as the healthimpairing effect of lead were demonstrated by measurements of lead and delta- aninolaevulinic acid in urine. After treatment with Calcium-Dinatrium-EDTA in order to eliminate lead the patients were cured and the lead content as well as the amount of deltaaminolaevulinic acid became normal. 59 of the residents nead the road had been treated in this way. Only one of these later died of cancer. Of 172 persons, who were not treated, 30 died of cancer, or ten times more percentage-wise. The concentrations of airborne lead and carcinogenic hydrocarbons in sedimented dust and in suspended dust were much grea- ter along the automobile road than in the traffic- free section. These findings together with many other reports in the medical literature lead to the suspi- cion that lead in gasoline, combined with other carcinogenic substances in automotive exhaust gases, increases the incidence of cancer. 11 CHELATION THERAPY IN OCCLUSIVE ARTERIOSCLEROSIS 0. BRflCKNEROVA 3 Internal Clinic, Purkyni University, Brno, CSSR In the course of the last 20 years fleJSDTA was applied in i.v. drop Infusions to a group of 65 patients( 51 men + 14 women) suffering from ocelusive arterial disease of the lower extremities. Each infusion contained 3 gme of Ka9EDTA (CHELATON III) dissolved in 500 ml of 5% fructose and lasted about 4 hours. Each cure consisted of 30 Infusions, one dai- ly, for 5 day8''each week. The whole cure lasted 6 weeks. In some patients the therapy waa repe- ated after a pause of 6 months. At the beginning of treatment the average age was 54 in men and 63 in women. In most of the patients multiple atherosclerotic lesions were present not only in the arteries of the limbs but also in the coronary and/or cerebral arte- ries* This limited the chance of surgical recon- struction* The therapy was well tolerated and an amelio- ration waa achieved namely in prolongation of the walking distance in stage II ( Fontaine)and the disappearance of rest-pain in stage III* In stage IV the results were less favourable. After long-term observation 34% of the group are ali- ve, 51% died and 15% are loat of evidence. The mechanisme of action is explained by some authors by disintegration of atherosclerotic pla- oues and elimination of metastati.s caloiua fram deposits which in not accompained by ceteoporo**. sis. 12 OBJECTIVE EVIDENCE OF THE EFFICACY OF CHELATION THERAPY BY RAOIONUCLIOE STUDIES IN PATIENTS WITH HEART AND BRAIN DISORDERS. H.R. Casdorph, M.D.,Ph.D., Casdorph Cinic, Long Beach, CA USA Eighteen patients with documented Atherosclerotic Heart Disease were studied using .Technetlun 99a to measure lefc ventricular ejection fraction at rest before and after the administration of 20 treatments of EDTA Chelation Therapy. A statistically significant improvement in the left ventricular ejection fraction Qccured in the treated group of patients.
Load more

Recommended publications
  • Alternative Testing Approaches in Environmental Safety Assessment
    Alternative Testing Approaches in Environmental Safety Assessment Technical Report No. 97 ISSN-0773-8072-97 Brussels, December 2005 Alternative Testing Approaches in Environmental Safety Assessment ECETOC TECHNICAL REPORT No. 97 © Copyright - ECETOC AISBL European Centre for Ecotoxicology and Toxicology of Chemicals 4 Avenue E. Van Nieuwenhuyse (Bte 6), B-1160 Brussels, Belgium. All rights reserved. No part of this publication may be reproduced, copied, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the copyright holder. Applications to reproduce, store, copy or translate should be made to the Secretary General. ECETOC welcomes such applications. Reference to the document, its title and summary may be copied or abstracted in data retrieval systems without subsequent reference. The content of this document has been prepared and reviewed by experts on behalf of ECETOC with all possible care and from the available scientific information. It is provided for information only. ECETOC cannot accept any responsibility or liability and does not provide a warranty for any use or interpretation of the material contained in the publication. ECETOC TR No. 97 Alternative Testing Approaches in Environmental Safety Assessment Alternative Testing Approaches in Environmental Safety Assessment CONTENTS SUMMARY 1 1. INTRODUCTION 3 2. BACKGROUND 5 2.1 Definitions 5 2.1.1 Definition of a protected animal 5 2.1.2 Ethical considerations of animal use 6 2.1.3 The three Rs 6 2.2 Information needs 7 2.2.1 The use of fish in ecotoxicology 7 2.2.2 Numbers of fish used 8 2.2.3 Regulatory tests - chemicals 8 2.2.4 REACH and its impact on the use of fish 9 2.2.5 Regulatory tests - effluents 9 2.3 Potential for alternatives 10 2.3.1 Reduction 10 2.3.2 Refinement 11 2.3.3 Replacement 11 2.4 Report structure 13 2.4.1 Atmosphere 14 2.4.2 Terrestrial hazard assessment 14 3.
    [Show full text]
  • “Six-Pack” Testing Strategy: Influx of Modern in Vitro Techniques Gertrude-Emilia Costin, Ph.D., M.B.A
    Modernizing the “six-pack” testing strategy: influx of modern in vitro techniques Gertrude-Emilia Costin, Ph.D., M.B.A. Institute for In Vitro Sciences, Inc. (IIVS) NorCal SOT Fall Symposium 2017 The 3Rs 28 September 2017, San Francisco, CA, USA Perspectives, challenges, common goals and working together Safety/ Testing Labs Labeling/ Industry/ Regulatory Manufacturer Agency Consumer/ End-user Safety Presentation Outline Current regulatory climate – global acceptance of in vitro methods The reductionist concept of in vitro methods Drivers of in vitro methods advancement Beyond the “six-pack” battery of acute toxicity tests Acute oral toxicity Acute dermal toxicity (oral vs dermal route comparison) Acute inhalation toxicity Ocular irritation (the EPA OPP testing strategy) Skin irritation/corrosion Skin sensitization Modernizing the “six-pack” testing strategy: influx of modern in vitro techniques Current regulatory climate – global acceptance of in vitro methods The reductionist concept of in vitro models 1940s 1990s Whole animal Organ - Eyeball Tissue - Cornea Cell culture (Rabbit) (Enucleated chicken or (Resected bovine (Statens Seruminstitut rabbit eye) cornea) Rabbit cornea cells) “Less is more” Retinal Pigment Epithelium Semi-permeable Membrane Vascular network Nutrient channels Fibrinogen- endothelial cell administration channel Body-on-a-chip Organ-on-a-chip Tissue construct Cell culture (Human organotypic (Human retina) (Human EpiCorneal™ (Normal human microtissues) model) corneal epithelial cells) 2010s 2000s G.-E. Costin and H. A. Raabe. In vitro toxicology models. In: The Role of the Study Director in Non-clinical Studies. Pharmaceuticals, Chemicals, Medical Devices, and Pesticides. (Eds. William Brock, Barbara Mounho and Lijie Fu), John Wiley and Sons (2014). G.-E. Costin.
    [Show full text]
  • Toxicity and Hazard of Pesticides
    Pesticide Toxicity and Hazard April, 2017 Introduction Pesticide applicators should understand the hazards and risks associated with the pesticides they use. Pesticides vary greatly in toxicity. Toxicity depends on the chemical and physical properties of a substance, and may be defined as the quality of being poisonous or harmful to animals or plants. Pesticides have many different modes of action, but in general cause biochemical changes which interfere with normal cell functions. The toxicity of any compound is related to the dose. A highly toxic substance causes severe symptoms of poisoning with small doses. A substance with a low toxicity generally requires large doses to produce mild symptoms. Even common substances like coffee or salt become poisons if large amounts are consumed. Toxicity can be either acute or chronic. Acute toxicity is the ability of a substance to cause harmful effects which develop rapidly following exposure, i.e. a few hours or a day. Chronic toxicity is the ability of a substance to cause adverse health effects resulting from long-term exposure to a substance. There is a great range in the toxicity of pesticides to humans. The relative hazard of a pesticide is dependent upon the toxicity of the pesticide, the dose and the length of time exposed. The hazard in using a pesticide is related to the likelihood of exposure to harmful amounts of the pesticide. The toxicity of a pesticide can’t be changed but the risk of exposure can be reduced with the use of proper personal protective equipment (PPE), proper handling and application procedures. Pesticide Toxicity Some pesticides are dangerous after one large dose (acute toxicity).
    [Show full text]
  • Acute Toxicity Testing Without Animals: More Scientific and Less of a Gamble
    WellBeing International WBI Studies Repository 3-2005 Acute Toxicity Testing Without Animals: More Scientific and Less of a Gamble Gillian R. Langley British Union for the Abolition of Vivisection Follow this and additional works at: https://www.wellbeingintlstudiesrepository.org/appamet Part of the Bioethics and Medical Ethics Commons, Design of Experiments and Sample Surveys Commons, and the Laboratory and Basic Science Research Commons Recommended Citation Langley, G. (2005). Acute toxicity testing without animals. London, UK: BUAV. This material is brought to you for free and open access by WellBeing International. It has been accepted for inclusion by an authorized administrator of the WBI Studies Repository. For more information, please contact [email protected]. Acute Toxicity Testing Without Animals ~ “more scientific and less of a gamble” Report by Dr Gill Langley MA PhD MIBiol CBiol March 2005 British Union for the Abolition of Vivisection (BUAV) 16a Crane Grove London N7 8NN United Kingdom Email: [email protected] Web: www.buav.org Contents Foreword 3 1. Introduction 4 2. The Case Against Acute Toxicity Tests on Animals 5 2.1 Human relevance of acute toxicity tests on animals 6 2.2 Reliability of acute toxicity tests on animals 9 2.3 Practicalities of acute toxicity testing on animals 10 2.4 Animal suffering in acute toxicity tests 11 3. Classification and Labelling 11 4. High-throughput Prioritisation – Not Mass Animal Testing 12 5. Existing Data, Read-across and (Q)SARs for Acute Toxicity 13 5.1 Existing data 14 5.2 Read-across 14 5.3 (Q)SARs 15 6. Non-Animal Tests for Acute Toxicity 15 6.1 Rapid screening for acute toxicity 16 6.2 Fuller assessment for acute toxicity 17 6.2.1 Absorption in vitro and in silico 18 6.2.2 Plasma levels and target organ effects in vitro 19 6.2.3 Metabolism in vitro 20 6.2.4 Toxicokinetic modelling 20 7.
    [Show full text]
  • Determination of Medium Lethal Dose (LD50) and Acute Toxicity of Formulation Cytoreg®, an Ionic Mixture of Strong and Weak Acids
    Latin American Journal of Development, Curitiba, v. 3, n. 3, p. 1121-1126, mai./jun. 2021. ISSN 2674-9297 Determination of medium lethal dose (LD50) and acute toxicity of formulation Cytoreg®, an ionic mixture of strong and weak acids. DOI: 10.46814/lajdv3n3-010 Recebimento dos originais: 01/05/2021 Aceitação para publicação: 30/06/2021 Rosa De Jesus Full Professor, Faculty of Sciences, Department of Biology, Director of the Bioterium, University of Los Andes Institute of Scientific Research and High Technology Service (INDICASAT AIP). Panamá. Email: [email protected] Nelson Vicuña-Fernández Full Professor, Department of Pharmacology and Toxicology, Faculty of Medicine, University of Los Andes Andrés Osorio Research Assistant, Bioterium of the University of Los Andes Chemists from Cytorex de Venezuela S.A, a subsidiary of Cytorex International Inc. David Martucci Company Researches from Cytorex de Venezuela S.A, a subsidiary of Cytorex International Inc. Lewis Pozo Company Researches from Cytorex de Venezuela S.A, a subsidiary of Cytorex International Inc. Carlos García A Company Researches from Cytorex de Venezuela S.A, a subsidiary of Cytorex International Inc. William Jimenez Company Researches from Cytorex de Venezuela S.A, a subsidiary of Cytorex International Inc. ABSTRACT A series of toxicological and pharmacological tests were started in the bioterium of the University of Los Andes, in order to evaluate a new formulation for therapeutic purposes. The present work reports the results found regarding the LD50 and the acute toxicity of this formulation produced by Cytorex of Venezuela, S.A. The new formulation supplied in liquid form, containing a variety of acid atoms whose conjugated bases have different electrical charges.
    [Show full text]
  • Toxicity Testing Requirements, Methods and Proposed Alternatives
    TOXICITY TESTING REQUIREMENTS, METHODS AND PROPOSED ALTERNATIVES Megan Erin Gallagher* I. INTRODUCTION Toxicology is the study of chemical substances that harm biological organisms.' Toxic exposure can occur transdermally through contact with the skin, orally and via inhalation.2 Toxicity testing is necessary to provide some basis for the regulation of substances that humans and other living things may come into contact with, intentionally or not. It is used to determine the safety of cosmetics, pharmaceuticals, food addi- tives., pesticides, chemicals, additives and consumer products. A toxic ef- fect can result from a natural or a manufactured substance and manifest a variety of symptoms, both immediate and long-term.' As a result, tox- icity testing introduces a variety of methods and rates of exposure to the test organism, in order to formulate a more accurate assessment of the risk of harm that the test substance may pose to human health and the environment. Most human knowledge of the toxicity of various chemicals is the result of animal research, though it is intended for the most part to extra- polate predicted human physiological response.4 Although there is no accurate numerical statistic available, animals are used by the millions annually for product testing in the United States. Under the Federal Animal Welfare Act, only dogs, cats, primates, rabbits, hamsters and guinea pigs are protected, and thus statistically counted for agency re- porting to the U.S. Department of Agriculture.' Undoubtedly countless more rodents [often mice and rats which constitute 85-90% of laboratory animals used] and other animals are experimented on annually and their * J.D.
    [Show full text]
  • Health Effects from Exposure to Acute Levels of Industrial Chemicals - Arito, Heihachiro
    ENVIRONMENTAL TOXICOLOGY AND HUMAN HEALTH – Vol. I - Health Effects from Exposure to Acute Levels of Industrial Chemicals - Arito, Heihachiro HEALTH EFFECTS FROM EXPOSURE TO ACUTE LEVELS OF INDUSTRIAL CHEMICALS Arito Heihachiro National Institute of Industrial Health, Kawasaki, Japan Keywords: Acute toxicity, MSDS, Dioxins, Non-regular work, Contents 1. Introduction 2. What is Acute Toxicity? 3. Occurrence of Acute Poisonings in Industries 4. Non-regular Work as a Causative Factor of Acute Poisoning 5. Occupational Exposure Limits and Acute Effects 6. Acute Exposure Guidelines 7. Acute Toxicity of Dioxins Bibliography Biographical Sketch 1. Introduction In modern society, chemical manufacturers endeavor to develop new chemicals for industrial use, and we enjoy benefits from many commercial products made of new and existing chemicals. When hazardous chemicals are manufactured in a poor work environment without adequate technical control, workers suffer acute and chronic poisonings from exposure to these industrial chemicals. Occupational diseases caused by exposure to hazardous chemicals have been a primary subject of concern for workers and occupational health specialists. Environmental health scientists are also concerned with the health consequences of releasing of hazardous chemicals into the environment outside an industrial plant. Such environmental release has caused catastrophes of acute poisoning among surrounding community residents. An accidental release of methylisocyanate from a chemical plant in Bhopal, India, killed two thousand community residents near the plant and caused acute poisoning in more than 2 000 people. In a chemical plant, Seveso, Italy, 2,4,5-trichlorophenol (TCP) containing 2,3,7,8-tetrachlorodibenzo-p-dioxinUNESCO (TCDD) – waEOLSSs discharged into the environment by a “runaway reaction” explosion of a reactor vessel for TCP production.
    [Show full text]
  • Toxicity and Hazard Exposure Contents
    Toxicity and Hazard Exposure Contents 1 Routes of Entry for Chemicals ............................................................................................................... 2 1.1 Inhalation ...................................................................................................................................... 2 1.2 Skin and Eye Contact (Absorption) ............................................................................................... 2 1.3 Ingestion........................................................................................................................................ 3 1.4 Injection ........................................................................................................................................ 3 2 Sites of Action ....................................................................................................................................... 3 3 Toxicology Overview ............................................................................................................................. 4 3.1 Acute Toxicity ................................................................................................................................ 5 3.2 Chronic Toxicity ............................................................................................................................. 6 3.3 Physical Class of Agent .................................................................................................................. 7 4 Hazard Exposure Guidelines ................................................................................................................
    [Show full text]
  • Introduction to Toxicology
    Toxicology TRAINING FOR THE HEALTH SECTOR Introduction to Toxicology Children's Health and the Environment CHEST Training Package for the Health Sector <<NOTE TO USER: Please add details of the date, time, place and sponsorship of the meeting for which you are using this presentation.>> 1 Toxicology Definition Toxicology Definition of toxicology is "the study of the adverse effects of chemicals or physical agents on living organisms The traditional definition of toxicology is "the science of poisons." As our understanding of how various agents can cause harm to humans and other organisms, a more descriptive definition of toxicology is "the study of the adverse effects of chemicals or physical agents on living organisms". Adverse effects may occur in many forms, ranging from immediate death to subtle changes not realized until months or years later. They may occur at various levels within the body, such as an organ, a type of cell, or a specific biochemical. Knowledge of how toxic agents damage the body has progressed along with medical knowledge. It is now known that various observable changes in anatomy or body functions actually result from previously unrecognized changes in specific biochemicals in the body. The textbooks listed below are quite comprehensive and widely used in basic toxicology training courses. Casarett and Doull's Toxicology (C. Klaassen, M. Amdur, and J. Doull, eds.) Principles and Methods of Toxicology (A. W. Hayes, ed.) Basic Environmental Toxicology (L. Cockerham and B. Shane, eds.) 2 Toxicology Philippus Theophrastus Aureolus Bombastus von Hohenheim PARACELSUS (Einsiedeln, Zürich, 1493 - Salzburg, 1541) All substances are poisons; it is the dose that makes the poison The historical development of toxicology began with early cave dwellers who recognized poisonous plants and animals and used their extracts for hunting or in warfare.
    [Show full text]
  • Advances in Acute Toxicity Testing: Strengths, Weaknesses and Regulatory Acceptance
    Interdiscip Toxicol. 2018; Vol. 11(1): 5–12. interdisciplinary doi: 10.2478/intox-2018-0001 Copyright © 2018 SETOX & IEPT CEM SASc. This is an Open Access article distributed under the terms of the Creative Commons Attri- bution-NonCommercial-NoDerivatives 4.0 License (https://creativecommons.org/licenses/ by-nc-nd/4.0). REVIEW ARTICLE Advances in acute toxicity testing: strengths, weaknesses and regulatory acceptance Earnest Oghenesuvwe ERHIRHIE, Chibueze Peter IHEKWEREME, Emmanuel Emeka ILODIGWE Department of Pharmacology and Toxicology, Nnamdi Azikiwe University, Agulu, Anambra State, Nigeria ITX110118A01 • Received: 27 November 2017 • Accepted: 13 December 2017 ABSTRACT Safety assessment of chemicals, pharmaceuticals, food and food ingredients, cosmetics, industrial products is very crucial prior to their approval for human uses. Since the commencement of toxicity testing (about 500 years ago, since 1520), significant advances have been made with respect to the 3Rs (reduction, refinement and replacement) alternative approaches. This review is focused on the update in acute systemic toxicity testing of chemicals. Merits and demerits of these advances were also highlighted. Traditional LD50 test methods are being suspended while new methods are developed and endorsed by the regulatory body. Based on the refinement and reduction approaches, the regulatory body has approved fixed dose procedure (FDP), acute toxic class (ATC) method and up and down procedure (UDP) which involves few numbers of animals. In terms of replacement approach, the regulatory body approved 3T3 neutral red uptake (NRU), the normal human keratinocyte (NHK), and the 3T3 neutral red uptake (NRU) phototoxicity test for acute phototoxicity. However, other promising replacement alternatives such as organ on chip seeded with human cells for acute systemic toxicity and 3T3 neutral red uptake (NRU) cytotoxicity test for identifying substances not requiring classification, as well as the in silico approaches are yet to receive regulatory approval.
    [Show full text]
  • Health Hazards Hazard Assessment & Risk
    Safe Operating Procedure (1/13) HEALTH HAZARDS HAZARD ASSESSMENT & RISK MINIMIZATION _____________________________________________________________________ (For assistance, please contact EHS at (402) 472-4925, or visit our web site at http://ehs.unl.edu/) Background The Globally Harmonized System (GHS) of classification and labeling of chemicals recognizes the following classifications of chemicals posing a health hazard. • Acute toxicity refers to those effects following oral or dermal administration of a single dose of a substance or multiple doses given within 24 hours, or an inhalation exposure of 4 hours. • Skin corrosion/irritation. Corrosion is the production of irreversible damage to the skin and chemicals assigned to this classification are addressed in the EHS SOP, Corrosive Chemical Hazards & Risk Minimization. Irritation is the production of reversible damage to the skin. The same general precautions for working with skin corrosives should be followed when working with skin irritants as described in the referenced SOP. • Serious eye damage/eye irritation is the production of tissue damage or serious physical decay of vision following application of a test substance to the anterior surface of the eye, which is not fully reversible within 21 days of application. Effects of contact with eye irritants are fully reversible with 21 days. Refer to the EHS SOP, Corrosive Chemical Hazards & Risk Minimization. • Respiratory or skin sensitization is described as hypersensitivity of the airways or allergic responses of the skin following inhalation/contact with a chemical substance. • Germ cell mutagenicity is described as mutations to germ cells of humans that can be transmitted to progeny after contact with a chemical. • Carcinogenicity is induction of cancer or its increased incidence after contact with a chemical or mixture.
    [Show full text]
  • Kidney and Heavy Metals - the Role of Environmental Exposure (Review)
    MOLECULAR MEDICINE REPORTS 15: 3413-3419, 2017 Kidney and heavy metals - The role of environmental exposure (Review) PAOLO LENTINI1*, LUCA ZANOLI2*, ANTONIO GRANATA3, SALVATORE SANTO SIGNORELLI2, PIETRO CASTELLINO2 and ROBERTO DELL'AQUILA1 1Department of Nephrology and Dialysis, ‘St. Bassiano’ Hospital, I-36061 Bassano del Grappa; 2Department of Internal Medicine, University of Catania, I-95124 Catania; 3Department of Nephrology ‘St. Giovanni di Dio’ Hospital, I-92100 Agrigento, Italy Received January 2, 2017; Accepted February 24, 2017 DOI: 10.3892/mmr.2017.6389 Abstract. Heavy metals are extensively used in agriculture 2. Mechanism of heavy metal toxicity and industrial applications such as production of pesticides, 3. Symptoms of exposure and toxicity batteries, alloys, and textile dyes. Prolonged, intensive or exces- 4. Laboratory testing sive exposure can induce related systemic disorders. Kidney is 5. Ultrasound examination a target organ in heavy metal toxicity for its capacity to filter, 6. Treatment reabsorb and concentrate divalent ions. The extent and the 7. Lithium expression of renal damage depends on the species of metals, 8. Cisplatin the dose, and the time of exposure. Almost always acute kidney 9. Cadmium impairment differs from chronic renal failure in its mechanism 10. Arsenic and in the magnitude of the outcomes. As a result, clinical 11. Mecrcury features and treatment algorithm are also different. Heavy 12. Lead metals in plasma exist in an ionized form, that is toxic and leads 13. Other heavy metals to acute toxicity and a bound, inert form when metal is conju- 14. Conclusion gated with metallothionein and are then delivered to the liver and possible causing the kidney chronic damage.
    [Show full text]